Berkshire Hathaway’s running earnings rise nearly 7%, funds pile techniques $150 billion

Berkshire Hathaway’s running earnings rise nearly 7%, funds pile techniques 0 billion


Key Points
  • The Omaha-based conglomerate’s running earnings totaled $10.043 billion last quarter, 6.6% better than the determine from the exact same quarter a year ago.
  • Net income totaled $35.91 billion, in comparison with a $43.62 billion loss in the course of the next quarter past year.
  • Berkshire’s large funds pile grew to $147.377 billion at the conclude of June, around a file and substantially higher than the $130.616 billion in the 1st quarter.



Supply

JPMorgan Chase reins in lending to private credit firms after marking down software loans
Finance

JPMorgan Chase reins in lending to private credit firms after marking down software loans

Key Points JPMorgan is marking down collateral held by private credit firms and reducing their borrowing capacity — a preemptive move driven by market valuations, not actual loan losses. The markdowns target software company loans, where AI advances have sparked fears of disintermediation, triggering a private credit downcycle and abnormally high redemptions at firms like […]

Read More
Stocks making the biggest moves premarket: Oracle, AeroVironment, Nike and more
Finance

Stocks making the biggest moves premarket: Oracle, AeroVironment, Nike and more

Check out the companies making headlines before the bell. Oracle — Oracle shares jumped more than 9% after the cloud infrastructure company gave strong fiscal third quarter results and lifted its revenue guidance for fiscal 2027. Management lifted its fiscal 2027 revenue outlook up $1 billion to $90 billion. Analysts polled by LSEG sought $86.6 […]

Read More
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More